- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- EXPERT BLOG: Provider status for pharmacists — one way or another
- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- New York's online database of drug prescriptions curtailing 'doctor shopping'
NEW YORK — One of the world's largest drug makers has entered a definitive agreement to purchase a Copenhagen-based consumer healthcare business.
Pfizer said Monday that it agreed to acquire from Altor 2003 Fund GP Limited Ferrosan’s consumer healthcare business, which includes a portfolio of such dietary supplements and lifestyle products as Multi-Tabs and Bifiform. Ferrosan caters to such markets as Russia, Ukraine, Poland, Turkey and many countries throughout Central and Eastern Europe.
Pfizer said the deal will help expand the distribution of its consumer healthcare brands, including Centrum and Caltrate. The company said it expects the deal to be completed in second quarter 2011.
Financial terms were not disclosed.